The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Afatinib (Afa) plus bevacizumab (Bev) combination after acquired resistance (AR) to EGFR-tyrosine kinase inhibitors (TKIs) in EGFR-mutant non-small cell lung cancer (NSCLC): Multicenter single arm phase II trial (ABC-study).
 
Akito Hata
Consulting or Advisory Role - AstraZeneca Japan; Boehringer Ingelheim; Chugai Pharma
Speakers' Bureau - AstraZeneca Japan; Boehringer Ingelheim; Chugai Pharma; Lilly Japan
Research Funding - AstraZeneca Japan (Inst); Boehringer Ingelheim (Inst)
 
Nobuyuki Katakami
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Janssen; Lilly; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Maruishi Pharma (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst)
 
Reiko Kaji
No Relationships to Disclose
 
Toshihide Yokoyama
No Relationships to Disclose
 
Toshihiko Kaneda
No Relationships to Disclose
 
Motohiro Tamiya
Speakers' Bureau - Asahi Kasei; AstraZeneca Japan; Boehringer Ingelheim; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb; Ono Pharmaceutical
 
Takako Inoue
No Relationships to Disclose
 
Hiromi Kimura
No Relationships to Disclose
 
Yukihiro Yano
No Relationships to Disclose
 
Daisuke Tamura
No Relationships to Disclose
 
Satoshi Morita
Honoraria - Boehringer Ingelheim; Chugai Pharma
Research Funding - Boehringer Ingelheim (Inst)
 
Shunichi Negoro
No Relationships to Disclose